ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

December 26, 2008

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Hiring Freeze Squeezes NIH, NCI

August 3, 1979

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982